Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23065454)

1.

agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci.

Park SY, Chong YP, Park HJ, Park KH, Moon SM, Jeong JY, Kim MN, Kim SH, Lee SO, Choi SH, Woo JH, Kim YS.

Infection. 2013 Feb;41(1):111-9. doi: 10.1007/s15010-012-0348-0. Epub 2012 Oct 12.

PMID:
23065454
2.

Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates.

Chong YP, Park SJ, Kim HS, Kim ES, Kim MN, Park KH, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS.

Medicine (Baltimore). 2013 Mar;92(2):98-108. doi: 10.1097/MD.0b013e318289ff1e.

PMID:
23429353
3.

Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.

Ok HS, Lee HS, Park MJ, Kim KH, Kim BK, Wi YM, Kim JM.

Korean J Intern Med. 2013 Nov;28(6):678-86. doi: 10.3904/kjim.2013.28.6.678. Epub 2013 Oct 29.

4.

Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.

Kim SH, Park WB, Lee KD, Kang CI, Kim HB, Oh MD, Kim EC, Choe KW.

Clin Infect Dis. 2003 Sep 15;37(6):794-9. Epub 2003 Aug 23.

5.

Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.

Khatib R, Johnson LB, Sharma M, Fakih MG, Ganga R, Riederer K.

Scand J Infect Dis. 2009;41(1):4-9. doi: 10.1080/00365540802441711.

PMID:
18821135
6.

Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?

de Sanctis JT, Swami A, Sawarynski K, Gerasymchuk L, Powell K, Robinson-Dunn B, Carpenter CF, Sims MD.

Diagn Mol Pathol. 2011 Sep;20(3):184-8. doi: 10.1097/PDM.0b013e318208fc47.

PMID:
21817905
7.

Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.

Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chen WJ, Chang SC, Hsueh PR.

Clin Infect Dis. 2012 Nov 15;55(10):1329-37. doi: 10.1093/cid/cis717. Epub 2012 Aug 20.

8.

Difference in agr dysfunction and reduced vancomycin susceptibility between MRSA bacteremia involving SCCmec types IV/IVa and I-III.

Jang HC, Kang SJ, Choi SM, Park KH, Shin JH, Choy HE, Jung SI, Kim HB.

PLoS One. 2012;7(11):e49136. doi: 10.1371/journal.pone.0049136. Epub 2012 Nov 12.

9.

Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.

Fowler VG Jr, Sakoulas G, McIntyre LM, Meka VG, Arbeit RD, Cabell CH, Stryjewski ME, Eliopoulos GM, Reller LB, Corey GR, Jones T, Lucindo N, Yeaman MR, Bayer AS.

J Infect Dis. 2004 Sep 15;190(6):1140-9. Epub 2004 Aug 12.

10.

Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.

Butterfield JM, Tsuji BT, Brown J, Ashley ED, Hardy D, Brown K, Forrest A, Lodise TP.

Antimicrob Agents Chemother. 2011 Dec;55(12):5433-7. doi: 10.1128/AAC.00407-11. Epub 2011 Sep 19.

11.
12.

Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.

Park HJ, Kim SH, Kim MJ, Lee YM, Park SY, Moon SM, Park KH, Chong YP, Lee SO, Choi SH, Woo JH, Kim YS.

J Infect. 2012 Dec;65(6):505-12. doi: 10.1016/j.jinf.2012.08.007. Epub 2012 Aug 14.

PMID:
22902942
13.

Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.

Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR.

J Antimicrob Chemother. 2010 Aug;65(8):1792-8. doi: 10.1093/jac/dkq188. Epub 2010 May 28.

14.

Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.

Ganga R, Riederer K, Sharma M, Fakih MG, Johnson LB, Shemes S, Khatib R.

J Clin Microbiol. 2009 Mar;47(3):590-5. doi: 10.1128/JCM.00397-08. Epub 2009 Jan 14.

15.

Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.

Ammerlaan H, Seifert H, Harbarth S, Brun-Buisson C, Torres A, Antonelli M, Kluytmans J, Bonten M; European Practices of Infections with Staphylococcus aureus (SEPIA) Study Group.

Clin Infect Dis. 2009 Oct 1;49(7):997-1005. doi: 10.1086/605555.

16.

Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.

Jang HC, Kim SH, Kim KH, Kim CJ, Lee S, Song KH, Jeon JH, Park WB, Kim HB, Park SW, Kim NJ, Kim EC, Oh MD, Choe KW.

Clin Infect Dis. 2009 Aug 1;49(3):395-401. doi: 10.1086/600295.

17.

Impact of reduced vancomycin MIC on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia.

Park SY, Oh IH, Lee HJ, Ihm CG, Son JS, Lee MS, Kim MN.

Antimicrob Agents Chemother. 2013 Nov;57(11):5536-42. doi: 10.1128/AAC.01137-13. Epub 2013 Aug 26.

18.

The effect of staphylococcal cassette chromosome mec (SCCmec) type on clinical outcomes in methicillin-resistant Staphylococcus aureus bacteremia.

Han JH, Edelstein PH, Bilker WB, Lautenbach E.

J Infect. 2013 Jan;66(1):41-7. doi: 10.1016/j.jinf.2012.09.001. Epub 2012 Sep 6.

19.

Community-associated methicillin-resistant Staphylococcus aureus bacteremia and endocarditis among HIV patients: a cohort study.

Furuno JP, Johnson JK, Schweizer ML, Uche A, Stine OC, Shurland SM, Forrest GN.

BMC Infect Dis. 2011 Oct 31;11:298. doi: 10.1186/1471-2334-11-298.

20.

Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.

Schreiber MP, Chan CM, Shorr AF.

J Crit Care. 2011 Aug;26(4):395-401. doi: 10.1016/j.jcrc.2010.09.002. Epub 2010 Oct 30.

PMID:
21036521
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk